Novo Nordisk received approval in China for pre-distribution storage of up to 48 hours at 2°C to 30°C.

On October 19, Novo Nordisk (NVO.US) announced that the National Medical Products Administration (NMPA) of China has approved an update to the product information for semaglutide injection (brand name: Ozempic): prior to initial use during distribution to patients, Ozempic can be stored at temperatures between 2°C and 30°C for up to 48 hours. According to Novo Nordisk, this approval makes Ozempic the first and only GLP-1 weight management treatment solution in China with this distribution flexibility.